| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
interleukin 1 receptor associated kinase 4 | 0.578 | 0.769 | 7.8E-09 |
|
disease | 0.310 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.330 | None | 0.500 | 1 | 0 | 2007 | 2018 | |||||||||
|
growth hormone receptor | 0.490 | 0.846 | 8.4E-05 |
|
disease | 0.340 | None | 0.500 | 1 | 0 | 2002 | 2013 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.310 | None | 0.500 | 1 | 0 | 1994 | 2018 | ||||||||
|
sulfotransferase family 1A member 1 | 0.554 | 0.769 | 3.0E-11 |
|
disease | 0.340 | None | 0.500 | 1 | 0 | 2000 | 2009 | ||||||||
|
cell division cycle 27 | 0.729 | 0.308 | 1.00 |
|
disease | 0.310 | None | 0.500 | 1 | 0 | 2013 | 2018 | ||||||||
|
toll like receptor 6 | 0.556 | 0.769 | 2.3E-05 |
|
disease | 0.350 | None | 0.600 | 1 | 0 | 2005 | 2010 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.350 | None | 0.600 | 1 | 0 | 2001 | 2014 | ||||||||
|
glutathione S-transferase alpha 1 | 0.561 | 0.731 | 1.7E-06 |
|
disease | 0.330 | None | 0.667 | 1 | 0 | 2005 | 2015 | ||||||||
|
valosin containing protein | 0.469 | 0.923 | 1.00 |
|
disease | 0.330 | None | 0.667 | 1 | 0 | 2004 | 2018 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.400 | None | 0.727 | 1 | 0 | 2005 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.400 | None | 0.727 | 1 | 0 | 1998 | 2019 | ||||||||
|
claudin 3 | 0.558 | 0.615 | 0.52 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2001 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.750 | 1 | 0 | 2004 | 2017 | ||||||||
|
mitogen-activated protein kinase kinase kinase 7 | 0.477 | 0.808 | 1.00 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2007 | 2015 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2014 | 2019 | ||||||||
|
H4 clustered histone 8 | 0.541 | 0.692 | 7.2E-06 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2009 | 2014 | ||||||||
|
interleukin 16 | 0.501 | 0.846 | 1.2E-10 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2008 | 2018 | ||||||||
|
cyclin dependent kinase 2 associated protein 2 | 0.544 | 0.808 | 0.79 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2007 | 2018 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
disease | 0.390 | None | 0.778 | 1 | 0 | 2003 | 2018 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.340 | None | 0.800 | 3 | 0 | 2006 | 2014 | ||||||||
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 | 0.610 | 0.577 | 0.83 |
|
disease | 0.340 | None | 0.800 | 1 | 0 | 2007 | 2019 | ||||||||
|
eukaryotic translation initiation factor 3 subunit H | 0.700 | 0.308 | 4.7E-02 |
|
disease | 0.350 | None | 0.800 | 1 | 0 | 2000 | 2006 | ||||||||
|
nuclear receptor coactivator 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.390 | None | 0.800 | 1 | 0 | 2002 | 2019 |